perampanel and Movement-Disorders

perampanel has been researched along with Movement-Disorders* in 2 studies

Reviews

1 review(s) available for perampanel and Movement-Disorders

Article	Year
[News in neurology 2013]. Revue medicale suisse, 2014, Jan-15, Volume: 10, Issue:412-413 In 2013, perampanel is approved as an add-on treatment for generalised and focal seizures in pharmaco-resistant epilepsy. New anticoagulants are superior to antivitamin K in stroke secondary prevention in case of atrial fibrillation. DBS remains a valid therapeutic option for advanced Parkinson's disease. Intranasal ketamine seems to reduce the intensity of severe migraine aura. High concentrations of topic capsaicin improve post-herpetic neuralgia. In Alzheimer's disease, statins might deteriorate cognitive functions. Oral immuno-modifing treatments for relapsing remitting multiple sclerosis have shown to slow cerebral atrophy progression at two years. Topics: Central Nervous System Agents; Cerebrovascular Disorders; Deep Brain Stimulation; Epilepsy; Headache Disorders; Humans; Movement Disorders; Neurology; Neuromuscular Diseases; Nitriles; Pyridones	2014

Article

Year

[News in neurology 2013].

Revue medicale suisse, 2014, Jan-15, Volume: 10, Issue:412-413

In 2013, perampanel is approved as an add-on treatment for generalised and focal seizures in pharmaco-resistant epilepsy. New anticoagulants are superior to antivitamin K in stroke secondary prevention in case of atrial fibrillation. DBS remains a valid therapeutic option for advanced Parkinson's disease. Intranasal ketamine seems to reduce the intensity of severe migraine aura. High concentrations of topic capsaicin improve post-herpetic neuralgia. In Alzheimer's disease, statins might deteriorate cognitive functions. Oral immuno-modifing treatments for relapsing remitting multiple sclerosis have shown to slow cerebral atrophy progression at two years.

Topics: Central Nervous System Agents; Cerebrovascular Disorders; Deep Brain Stimulation; Epilepsy; Headache Disorders; Humans; Movement Disorders; Neurology; Neuromuscular Diseases; Nitriles; Pyridones

2014

Other Studies

1 other study(ies) available for perampanel and Movement-Disorders

Article	Year
Perampanel treatment in Early-onset Epileptic Encephalopathy with infantile movement disorders associated with a de novo GRIN1 gene mutation: a 3-year follow-up. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:4 Topics: Follow-Up Studies; Humans; Infant; Movement Disorders; Mutation; Nerve Tissue Proteins; Nitriles; Pyridones; Receptors, N-Methyl-D-Aspartate; Spasms, Infantile	2021

Article

Year

Perampanel treatment in Early-onset Epileptic Encephalopathy with infantile movement disorders associated with a de novo GRIN1 gene mutation: a 3-year follow-up.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:4

Topics: Follow-Up Studies; Humans; Infant; Movement Disorders; Mutation; Nerve Tissue Proteins; Nitriles; Pyridones; Receptors, N-Methyl-D-Aspartate; Spasms, Infantile

2021